Robert Van Nostrand

Bob Van Nostrand has been associated with NewYorkBIO for more than two decades. He was CFO of OSI Pharmaceuticals for over 20 years, helping to grow the company from an early phase to a major acquisition target. He has also been CFO of Aureon and is a member of the Board of Directors of Achillion.